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Abstract
Array comparative genomic hybridization(CGH) is a high resolution technique to assess DNA
copy number variation. Identifying breakpoints where copy number changes will enhance the under-
standing of the pathogenesis of human diseases, such as cancers. However, the biological variation
and experimental errors contained in array CGH data may lead to false positive identification of
breakpoints. We propose a robust state space model for array CGH data analysis. The model con-
sists of two equations: an observation equation and a state equation, in which both the measurement
error and evolution error are specified to follow t-distributions with small degrees of freedom. The
completely unspecified CGH profiles are estimated by a Markov Chain Monte Carlo(MCMC) algo-
rithm. Breakpoints and outliers are identified by a novel backward selection procedure based on
posterior draws of the CGH profiles. Compared to three other popular methods, our method demon-
strates several desired features, including false positive rate control, robustness against outliers, and
superior power of breakpoint detection. All these properties are illustrated using simulated and real
datasets.
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1 Introduction
Almost all types of cancer share one common characteristic, genetic instability, including DNA copy
number variation(CNV). During cancer progression some genes will lose one of the two copies or are
completely deleted, while others may gain one copy, or become amplified up to hundreds of copies.
These chromosomal alterations can lead to abnormal cell proliferation, DNA repair, senescence
and apoptotic mechanisms and can provide a selective advantage for cells and result in cancer.
Identification of CNV not only enhances the understanding of oncogenesis but also facilitates the
treatment of cancer. For example, Trastuzumab is a monoclonal antibody interfering with ERBB2
receptor and is used for the treatment of breast cancers with amplified, and multiple copies of the
ERBB2 gene (Vogel et al., 2002).
Array comparative genomic hybridization (CGH) is a technique that is used to detect differ-
ences in DNA copy number (Solinas-Toldo et al., 1997; Pinkel et al., 1998). The isolated DNA
from tumor and the normal tissue from each patient are labeled with different fluorescent dyes
and then cohybridized to the microarray. The log2 fluorescent intensity ratios are measured at
different chromosomal positions to define each CGH profile. This CGH profile is supposed to be
proportional to the copy number ratio for tumor and normal cells across the chromosome. See
Pinkel & Albertson (2005) and Davies et al. (2005) for detail reviews. Array CGH data exhibit
three challenging characteristics. First, the data displays abrupt changes at the positions where
DNA copy number is possibly altered. Second, the data usually contain biological variations and
experimental errors, which hinder the accurate identification of breakpoints where copy number
changes. Biological variations refer to heterogeneity of copy number within tumor cells and ex-
perimental errors include contamination of the tumor cells with normal cells, measurement errors
and errors caused by processing tissue samples. Third, the data are spatially dependent. That is,
neighboring genes are more likely to share the same copy number than remote ones. The primary
aim of array CGH data analysis is to estimate the CGH profiles and to identify breakpoints from
available noisy observations.
A number of statistical methods have been proposed for array CGH data analysis. Most of the
methods postulate that the observed log2 intensity ratio Y (tj) is governed by the following model,
Y (tj) = µ(tj) + ε(tj), j = 1, 2, . . . , J (1)
where signal µ(tj) is the true log2 intensity ratio at jth probe, ε(tj) is noise and tj denotes the
2
physical position of jth probe on a chromosome. Different assumptions and interpretations of µ(tj)
and ε(tj) lead to various estimation approaches, which may be categorized into three types. The
first type is based on the segmentation method. It assumes that the CGH profile µ(t), is piecewise
constant, i.e. µ(tj) =
∑M
m=1 µmI[tj ∈ Tm], where Tm is segment m with mean µm and I(·) is the
indicator function. Also ε(tj) follows independent and identically distributed (i.i.d.) N (0, σ2ε).
To detect breakpoints that enable us to classify chromosome into blocks, Olshen et al. (2004)
and Venkatraman & Olshen (2007) proposed the method of circular binary segmentation(CBS);
Hupe et al. (2004) developed the adaptive weighted smoothing procedure; and Erdman & Emerson
(2008) implemented a Bayesian change point model.The second type is the method of hidden
Markov models (HMM), which restricts µ(t) to take a finite number of values and uses a Markov
chain to model probabilities: Pr(µ(tj+1) = µm′ | µ(tj) = µm), µm, µm′ ∈ U , with state space
U = {µm;m = 1, 2, . . . ,M}. Note that M is a prespecified number of states. The HMM method
was first applied to array CGH data analysis by Fridlyand et al. (2004). Shah et al. (2006) modified
the HMM method to achieve robustness against outliers. A continuous-index HMM was developed
by Stjernqvist et al. (2007). Guha et al. (2008) derived a Bayesian approach to the HMM with
objective decision rules. A segmental maximum posteriori approach(SMAP) by Andersson et al.
(2008) has incorporated both genomic distance and overlap between clones into the HMM. Finally,
the third type is built upon penalization methods, which essentially relax the piecewise constant
assumption by imposing a roughness penalty on CGH profile µ(t). In a penalization method, we
consider minimizing an objective function of the form Q = Qgf + Qsp, where the first term Qgf
measures the goodness of fit for profile µ(t) to the observed process Y (t) at observed probes t′js,
and the second term Qsp regularizes the smoothness of µ(t). Various forms of Qgf and Qsp have
been proposed in the literature, including quantile smoothing (Eilers & De Menezes, 2005), LASSO
(Huang et al., 2005), fused quantile regression(Li & Zhu, 2007) and fused LASSO (FLASSO) by
Tibshirani & Wang (2008).
Besides the three types of methods, there are other approaches; for example, clustering algo-
rithm (Wang et al., 2005; Liu et al., 2006), wavelet transform (Hsu et al., 2005) and ridge regression
(van de Wiel et al., 2009), among many others. Comprehensive comparisons among some of afore-
mentioned methods were given by Lai et al. (2005) and Willenbrock & Fridlyand (2005). Some of
the methods only estimate the profiles but do not directly call the breakpoints. Further, most
methods do not control the false positive rate for breakpoint identification, and their performances
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are significantly effected by the experimental errors, such as outliers.
In this paper, we propose a new method based on robust state space models for array CGH
data to estimate the CGH profile and to identify breakpoints under controlled false positive rates.
In addition, this new method has a number of desirable properties: (1) it is robust against outliers;
(2) it incorporates physical distance between probes into CNV identification; (3) it enables us to
quantify estimation uncertainties of signals via posterior credible intervals; (4) all the parameters are
estimated as part of the MCMC algorithm and thus are highly data-adaptive; (5) the computational
efficiency of the MCMC algorithm for profile estimation is proportional to the number of probes,
which helps the computation speed for high-throughput array CGH data analysis.
The rest of the paper is organized as follows. In Section 2, we first present the robust state
space model, then describe an MCMC algorithm to draw samples of both profiles and parameters,
and also outline a novel procedure of calling the breakpoints and outliers using MCMC samples.
In Section 3, the proposed model and method are applied to both simulated and real datasets for
illustration, where we compare our new method to three popular existing methods. We finally give
conclusions and discussion in Section 4.
2 Methods
2.1 Model
For the ease of exposition, we denote Yj = Y (tj), µj = µ(tj) and εj = ε(tj). The proposed
robust state space model(RSSM) comprises two equations: an observation equation and a state
equation. The observation equation is given in equation (1), where error εj is assumed to be
i.i.d and follow t-distribution, Tυε , with degree of freedom(d.f.) υε. Note that t-distribution is a
scale-mixture of normal distribution and gamma distribution. Thus, we rewrite εj ∼ N (0, σ2ε,j) a
normal distribution with mean 0 and variance σ2ε,j, and let σ
−2
ε,j = λε,jτε and λε,j ∼ G(υε/2, υε/2) a
gamma distribution with shape parameter υε/2 and rate parameter υε/2. The priors are specified
as υε ∼ G(10−3, 10−3)I(2, 10) and τε ∼ G(10−3, 10−3) throughout the paper.
We regard the signal µ(tj) as a continuous quantity which measures the log2 of average copy
number of heterogeneous tumor cells versus homogeneous normal cells. The state equation is:
µj+1 = µj + ξj, (2)
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where the evolution error or signal difference ξj follows an i.i.d t-distribution with d.f υξ. Sim-
ilar to the specification of εj, we let ξj ∼ N (0, σ2ξ,jδj), δj = tj+1 − tj, σ
−2
ξ,j = λξ,jτξ and λξ,j ∼
G(υξ/2, υξ/2), with the priors υξ ∼ G(10−3, 10−3)I(0.01, 2) and τξ ∼ G(10−3, 10−3). As a result,
εj ∼ Tυε(0, τ
−1
ε ) and ξj ∼ Tυξ(0, δjτ
−1
ξ ) marginally. Unlike other robust state space models (West,
1984; Fahrmeir & Ku¨nstler, 1999), our model incorporates the physical distance δj between two
probes to address the feature that the farther two probes are apart, the larger the signal difference
ξj is likely to be. Note that degree of freedom υξ is limited below 2. In this way, we hope that the
distribution Tυξ can accommodate extremely large values of signal difference probably caused by
breakpoints. A similar strategy was suggest by Kitagawa (1987), where differences of signals are
modeled by a distribution in the Pearson system with no finite second moments. As shown in his
paper, the Pearson system distribution facilitates the detection of mean structure changes.
2.2 Signal extraction by MCMC
With the model formulation given in Section 2.1, we now outline an MCMC algorithm to sample
from the posterior distribution for signals µ = [µ1, µ2, . . . , µJ ]
⊤, parameters φo = [λε,j, υε, τε] and
φs = [λξ,j, υξ, τξ] for j = 1, 2, . . . , J , given the data Y = [Y1, Y2, . . . , YJ ].
• Given Y , φo and φs, update the µ by the simulation smoother (Durbin & Koopman, 2002), a
multi-state Gibbs sampler which very efficiently draws samples from the posterior distribution
of signals µ.
• Given Y and µ, update φo according to the following steps:
[λε,j |· ] ∼ G(
υε
2
+ 1
2
, υε
2
+
(Yj−µj)2τε
2
);
[υε |· ] =
∏J
j=1 G(λεj |
υε
2
, υε
2
)G(υε | 10−3, 10−3)I(2, 10), by Adaptive Metropolis Rejection
Sampling (ARMS; Gilks et al., 1995);
τε ∼ G(
J
2
+ 10−3,
∑J
j=1
(Yj−µj)2λεj
2
+ 10−3).
• Given µ, update φs through the following steps:
[λξ,j |· ] ∼ G(
υξ
2
+ 1
2
,
υξ
2
+
(µj+1−µj)2τξ
2δj
);
[υξ |· ] =
∏J
j=1 G(λξj |
υξ
2
,
υξ
2
)G(υξ | 10−3, 10−3)I(0.01, 2), by the ARMS;
τξ ∼ G(
J
2
+ 10−3,
∑J
j=1
(µj+1−µj)2λξj
2δj
+ 10−3).
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According to the definition of errors εj = Yj −µj and ξj = µj+1−µj , we obtain the posterior draws
of the errors ε = [ε1, ε2, . . . , εJ ]
⊤ and the signal differences ξ = [ξ2, ξ3, . . . , ξJ ]
⊤. Samples of ε and
ξ are essential to identify outliers and breakpoints through a novel backward selection procedure
detailed in Section 2.3 below.
2.3 Breakpoints and outliers calling
Breakpoints are called by our backward selection procedure outlined in Algorithm 1 given in the
Supplementary Material. The input to the algorithm is the posterior draws of signal differences ξ,
in an m × n matrix, with m denoting the number of draws and n equal to the number of probes
minus one, as well as an input of a threshold qα. The specification of qα is discussed in detail
below. At line 6 in Algorithm 1, we calculate P˜j, which is an estimate of the posterior probability
P [|ξj| > |ξ−j| | Y ]. This is the probability of the absolute value of signal difference at position j is
larger than those at any other positions, given the data. The quantity P [|ξj| > |ξ−j| | Y ] represents
the area under the ROC curve or AUC (Pepe, 2004, Ch.4). It is known that AUC measures the
separation between the posterior distribution of |ξj| and that of the remaining |ξ−j|, namely all |ξi|
with i 6= j. Under the null hypothesis that probe j is not a breakpoint, we expect P˜j to be near
0.5. The decision of rejection of the null hypothesis will be based on the comparison of P˜j with
the threshold qα. In the first iteration of procedure, several P˜
′
js may be larger than qα; we take
the largest one and call it a breakpoint. This called position will be excluded from the subsequent
iterations. we repeat his calling procedure for the remaining ξj until none of the remaining P˜j is
above the threshold qα or all n−1 breakpoints are selected. The output of the algorithm is a list of
identified breakpoints. Likewise, we utilize this backward selection procedure to call outliers, based
on the posterior draws of errors ε.
In the above backward selection procedure for the calling of breakpoints, the qα is determined
such that under the null hypothesis that probe i is not a breakpoint, it will be chosen with probability
α(i.e. α is false positive rate). When a normal reference array is available, we can measure log2
intensity ratio of normal versus normal tissue. Fitting the proposed state space model to the normal
reference array, we obtain the posterior draws of signal differences ξo, where we can obtain P˜ o
′
j s
according to Algorithm 1. These P˜ oj , j = 1, 2, . . . , J
o, can be regarded as a random sample from a
distribution under the null hypothesis. Then, the qα is obtained as the (1− α) quantile of all P˜ o′j s.
6
This quantile qα implies that under the null hypothesis, the rate of false positive is α. In some real
experiments, normal reference arrays however may not be available. In this case, we can generate
a pseudo normal reference array Y o = [Y o1 , Y
o
2 , . . . , Y
o
Jo] by sampling with replacement from the
data Y . In this case, if some Y ′j s in the aberration region are sampled, they will be dispersed and
scattered randomly within the set Y o. Thus, they appear most likely as outliers rather than a
contiguous pattern of changes. Since the proposed state space model is robust against outliers, the
qα under the null hypothesis can be reasonably determined. Given the pseudo normal array, the
steps to obtain the qα are the same as those given in the scenario of the normal reference array
being available.
3 Applications
3.1 Simulation study
We first evaluate our proposed method and compare it with three other popular methods, FLASSO,
CBS and SMAP, using well known artificial chromosomes simulated by Lai et al. (2005). Lai et al.’s
data consist of 100 chromosomes, each with length 100. In the center of each chromosome is added
an aberration of copy number gain, which has one of the four different width (5,10,20 and 40). The
signal-to-noise ratio(SNR) is 1, and the noise follows a normal distribution with standard deviation
0.25.
We use the Receiver Operating Characteristic(ROC) curve to compare the performance of the
four methods in each width case. To obtain ROC curves, we compare the estimated signal µˆj at each
location with a cutoff varying from the minimum to the maximum of Y , and regard the location
i where µˆi is above the cutoff as the detected aberration region. The true positive rate(TPR) is
defined as the proportion of the true aberration region detected as an aberration region, while the
false positive rate(FPR) is defined as the proportion of the normal region declared as an aberration
region. The TPRs and FPRs are plotted as ROC curves in Figure 1. For the Lai et al.’s data, the
plots at the first row in Figure 1 indicate that our approach performs clearly better than CBS and
SMAP methods, in terms of higher TPR and lower FPR, not as well as FLASSO for the narrow
regions but comparably to FLASSO for the wide aberrations(20 and 40).
The simulated data in Lai et al. (2005) is idealized, and does not contain any of the complex
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features that occur in real data. Outliers are commonly seen in real datasets for various reasons,
including single probe amplification/deletion or experimental errors. To investigate the effect of
outliers, in Lai et al.’s simulated dataset, we add five percent of outliers in each chromosome at
randomly selected positions with magnitudes uniformly distributed over interval (3, 6). The ROC
curves given at the second row in Figure 1 clearly show the advantage of the proposed method.
Comparing to the corresponding cases in the first row, the ROC curves of FLASSO, CBS and SMAP
are considerably closer to the diagonal line, demonstrating a significant loss of prediction power for
the detection of CNVs. In contrast, the ROC curve of the proposed approach is affected very little,
indicating clearly that our method is robust to outliers.
Another feature of the real data is the possibility of more than one region of aberration with
different magnitudes. To evaluate the performance of the methods, we explore cases when two
aberration regions are present in the simulated chromosome simultaneously. For each Lai et al.’s
simulated chromosome, a randomly selected normal region of width five is replaced by an aberration
block with SNR 4. Based on the ROC curves plotted in the third row of Figure 1, the proposed
approach outperforms the three other approaches.
An important task in array CGH analysis is to correctly identify breakpoints. We investigate the
number of breakpoints identified by the four methods for each chromosome in the above simulated
data. In addition, we simulated normal chromosomes without any aberration regions. For these we
generate 100 normal chromosomes, each with 100 probes simulated from N (0, 0.252). In addition,
another 100 chromosomes are generated by adding outliers to the 100 normal chromosomes, in the
same way described above. For FLASSO, CBS and SMAP, a breakpoint is defined as a position j,
if the difference is non-zero, that is, ∆µˆj = µˆj+1 − µˆj 6= 0. For the proposed method, a breakpoint
is called by the backward selection procedure as described in Algorithm 1. To determine the qα, we
simulate a normal reference array with each probe asN (0, 0.252) with length Jo = 1000 and generate
the pseudo normal reference arrays with length Jo = 1000 through sampling with replacement from
the artificial chromosomes. The false positive rate α is set at 0.001, which means that for every
1000 probes in the normal reference array, one probe is expected to be falsely called as a breakpoint.
Figure 2 shows the side-by-side boxplots of the number of breakpoints identified by each of four
method respectively, where the qα is determined with simulated normal reference arrays and pseudo
normal reference arrays, respectively, for RSSM0 and RSSM1 corresponding to the first two boxplots
in each panel. From a comparison of these boxplots, it is clear that the number of breakpoints is
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over-estimated substantially by FLASSO in all the three scenarios although the magnitude of the
signal difference at some of these breakpoints may by quite small. The true number of breakpoints,
on average, is more likely to be correctly achieved by the proposed method, in scenario of two pieces
of aberration regions or in the cases where the aberration widths are as wide as 20 and 40. For the
normal chromosomes with or without outliers, both CBS and our method correctly conclude that
there are no breakpoints, while FLASSO identifies a few number of false breakpoints. Note that our
method identifies a total of 6 and 13 breakpoints for 10,000 probes in 100 normal chromosomes by
using, respectively, simulated and pseudo normal reference arrays. These number of false discoveries
numbers are close to the expected number 10, given the false positive rate 0.001. We also notice
that the numbers of breakpoints identified in the simulated and pseudo normal reference arrays are
very close to each other, which validates the utility of pseudo normal reference arrays when the
normal reference arrays are not available.
[Figure 1 about here.]
[Figure 2 about here.]
3.2 Glioblastoma Multiforme(GBM) data
GBM data by Bredel et al. (2005) include 26 samples representing primary GBMs, the most malig-
nant type of brain tumor. In sample GBM31, a large region of loss is demonstrated on chromosome
13, which is also observed by Koschny et al. (2002) in a meta-analysis of 509 cases. Besides losses,
the GBM data also contain a number of amplifications, one of which is shown on chromosome 7
in sample GBM29. Lai et al. (2005) compared the performance of various methods based on these
two chromosomes 13 and 7 with challenging features. They represent wider, low level region of loss,
and narrower, high level region of amplification, respectively. To assess our proposed method, we
re-analyze these two chromosomes using our method. The analysis is based on 1000 MCMC draws
from a single chain of 75, 000 iterations with 25, 000 burn-in period and every 50th being recorded.
As shown in Figure 3 , our method successfully detects both the loss region and amplification region
as well as some outliers. Both breakpoints and outliers are called using the proposed backward se-
lection procedure. The threshold for breakpoints is obtained through the pseudo normal reference
arrays with qξ0.001 = 0.911 for chomosome 7 and q
ξ
0.001 = 0.882 for chomosome 13. The threshold
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for outliers is chosen as qε = 0.98. The panels in Figure 3 also illustrate posterior means and 95%
credible intervals for signal µj, error εj and signal differences ξj across the chromosomes. At a given
position, the wider interval indicates higher uncertainty. Note that 95% credible intervals of signal
difference illustrate the corresponding posterior distributions. The further the credible interval de-
parts from the others along with the narrower width, the stronger it indicates the corresponding
position is a breakpoint. We also analyze the GBM data using the methods of FLASSO, CBS and
SMAP. As Figure 4 shown, all three methods can identify the two aberration regions, except SMAP
method that fails to detect any aberration region for chromosome 13.
Table 1 lists the number of breakpoints identified by each of the four methods. Our method and
CBS reach the same numbers on both chromosomes, which are much less than the those found by
FLASSO.
[Figure 3 about here.]
[Figure 4 about here.]
[Table 1 about here.]
3.3 Breast tumor data
Fridlyand et al. (2006) considered array CGH data from across 2464 genomic clones in 62 sporadic
ductal invasive breast tumors and 5 BRCA1 mutant tumors. We apply our method as well as other
three methods to analyze four chromosomes(8,11,17 and 20) of tumor ”S1539”, in which there are
a number of low level gains and losses as well as high level amplifications. The results of our
method are based on 1000 MCMC draws from a single chain of 75, 000 iterations with 25, 000 burn-
in period and every 50th being recorded. The backward selection procedure has been applied to
identify a number of breakpoints and outliers/amplifications. The qε is specified as 0.98, and qξ0.001
is determined using the pseudo normal reference arrays, resulting in values of 0.795, 0.789, 0.808
and 0.807 for chromosome 8,11,17 and 20 respectively. Figure 5 displays the posterior means and
95% credible intervals of signal µj , error εj and signal differences ξj across the chromosomes, as well
as a number of called outliers and breakpoints. These breakpoints define the edges of aberration
regions which include several well-known oncogenes, that play key roles in the pathogenesis of breast
tumor. The detected regions cover gene FGFR I between 36.4Mb and 39.7Mb on chromosome 8,
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gene CCND I between 68.5Mb and 77.0Mb on chromosome 11, and gene ZNF217 between 44.4Mb
and 62.7Mb on chromosome 20. Gene ERBB2 between 34.1Mb and 38.7Mb on chromosome 17 is a
well known gene that can be amplified in breast cancer. There are very few probes close to ERBB2,
and the method detected a probe as an outlier in this region.
We also analyze the same breast tumor data by FLASSO, CBS and SMAP methods. The
results are shown in Figure 6. We can see that the SMAP method appears to be very sensitive to
outliers(e.g. in chromosome 11) and local features(e.g. in chromosome 20), which has obscured the
estimate of the global trend. The CBS method failed to capture the single probe amplification in
the chromosome 17 and the weak gain in chromosome 20. The FLASSO method is also sensitive to
outliers, e.g. at the beginning of chromosome 8 and in the middle of chromosome 11. The number
of breakpoints identified by each of the methods is summarized in Table 1. FLASSO identifies a
large number of breakpoints, our method identifies slightly more breakpoints than CBS and slightly
fewer than SMAP.
[Figure 5 about here.]
[Figure 6 about here.]
4 Discussion
In this paper, we have proposed a powerful new method based on a robust state space model to
detect CNVs from array CGH data. A key feature of the proposed method is the use of heavy tail
t-distributions, which facilitates the robustness in the calling of breakpoints and outliers. Through
an MCMC algorithm, our approach presents an appealing method for CGH profile estimation
and detection of breakpoints. Our method is based on a probability model that gives not only
point estimation, but also uncertainty intervals for the signal, signal difference and measurement
error magnitudes, as illustrated in Figure 3 and 5. Such displays are very useful for visualizing
the data and the degree of confidence in any conclusion. We developed a novel backward selec-
tion procedure to effectively utilize the MCMC samples in the identification of breakpoints and
outliers/amplifications. Importantly, we control the false positive rate of feature detection at a
prespecified level by using real or pseudo normal reference arrays. As illustrated by both simulated
and real datasets, our approach has demonstrated superior detection power for aberration regions
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and breakpoints, and outperforms other existing methods in most of cases, especially for noisy data
with outliers.
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Supplementary Material
Algorithm 1 Backward selection procedure for the breakpoints
Input: Mm×n, qα
1. J ← ∅ and flag ← true
2. repeat
3. for j = 1 to n and j /∈ J do
4. V−j ← m samples without replacement from columns I of M , I = {i : i 6= j and i /∈ J }
5. Vj ← column j of M
6. P˜j =
1
m2
∑m
k=1
∑m
k′=1 I(|Vj[k]| > |V−j[k
′]|)
7. end for
8. if ∃j ∈ {1, 2, . . . , n} and j /∈ J : P˜j > qα then
9. j ← j : P˜j > P˜j′ all j′ 6= j
10. J ← J ∪ {j}
11. else
12. flag ← false
13. end if
14. until flag = false or number of elements in J = n− 1
15. if number of elements in J = n− 1 then
16. J ← {1, 2, . . . , n}
17. end if
Output: J
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Figure 1: ROC curves of four methods at SNR 1. — Our model,− −− FLASSO, − ·− CBS, · · ·
SMAP.
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Figure 2: Breakpoints identification using simulated and pseudo normal reference arrays. The hori-
zontal reference lines indicate the true number of breakpoints. The simulated normal reference array
is labeled by RSSM0, while RSSM1 utilizes pseudo normal reference arrays based on resampling
the observed data. The panel on bottom left is the replicate of the one on top left.
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Figure 3: GBM panel plots for the posterior distributions of measurement error, signal, and signal
difference by state space model. In the top and bottom panels, the • denotes the posterior mean
and | stands for the 95% credible intervals. In the middle panel, gray • is the data point and —is
posterior mean and 95% credible intervals are the shaded areas. vdenotes the selected outliers and
breakpoints.
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Figure 4: Panel plots of signal(—) estimated for GBM data by FLASSO, CBS and SMAP, where
gray • denotes the data point.
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Figure 6: Panel plots of signal(—) estimated for breast tumor data by FLASSO, CBS and SMAP,
where gray • denotes the data point.
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Table 1: The number of breakpoints identified in GBM and Breast Tumor data
GBM data Breast Tumor data
CH7 CH13 CH8 CH11 CH17 CH20
RSSM(ours) 6 1 9 5 3 5
FLASSO 15 15 30 19 29 12
CBS 6 1 3 6 0 2
SMAP 4 0 6 11 8 9
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